{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:37:24Z","timestamp":1787017044221,"version":"build-2736575974"},"reference-count":57,"publisher":"BMJ","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1991,9]]},"abstract":"<jats:p>The hydrophilic bile acid ursodeoxycholic acid has recently been shown to reduce biochemical markers of both cholestasis and hepatocellular damage in patients with chronic liver diseases. The most compelling evidence available is for chronic cholestatic liver diseases, in particular primary biliary cirrhosis, primary sclerosing cholangitis, and cholestasis associated with cystic fibrosis. The effects may be less beneficial in patients with advanced liver disease from these conditions. Data from placebo controlled trials are now available in support of earlier uncontrolled observations, but it is not yet clear whether short term benefit results in an improvement in longterm prognosis. The mechanism of action of the compound seems to reside in its displacement of toxic hydrophobic bile acids from both the bile acid pool and hepatocellular membranes. There may be an independent effect on bile flow, which could be of particular importance in cystic fibrosis, and possibly an effect on the immune system. Ursodeoxycholic acid should now be regarded as occupying a central place in the medical management of chronic cholestatic liver diseases, in particular primary biliary cirrhosis, because it improves cholestasis and reduces hepatocellular damage and it is not toxic. Research should now be targeted on whether treatment with ursodeoxycholic acid, initiated early in cholestatic liver conditions, improves the long-term outcome.<\/jats:p>","DOI":"10.1136\/gut.32.9.1061","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"1061-1065","source":"Crossref","is-referenced-by-count":36,"title":["Ursodeoxycholic acid in chronic liver disease."],"prefix":"10.1136","volume":"32","author":[{"given":"J S","family":"de Caestecker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R P","family":"Jazrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M L","family":"Petroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T C","family":"Northfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1991,9,1]]},"reference":[{"key":"ref_1","first-page":"43","article-title":"Hepatoprotective effect of ursodeoxycholic acid in experimental animals","volume-title":"Strategies for the treatment of hepatobiliary diseases","author":"Kitani, K.","year":"1990","unstructured":"Kitani K. Hepatoprotective effect of ursodeoxycholic acid in experimental animals. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer Academic, 1990: 43-56."},{"key":"ref_2","first-page":"13","article-title":"Bile acid hepatoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypotheses","volume-title":"Strategies for the treatment of hepatobiliary diseases","author":"Hofmann, A.F.","year":"1990","unstructured":"Hofmann AF. Bile acid hepatoxicity and the rationale of UDCA therapy in chronic cholestatic liver disease: some hypotheses. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer Academic, 1990: 13-33."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/BF01308413","article-title":"Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two year follow up: a pilot study","volume":"30","author":"Leuschner, U.; Leuschner, M.; J, Sieratzki; Kurtz, W.; Hubner, K.","year":"1985","unstructured":"Leuschner U, Leuschner M, Siera.tzki J, Kurtz W, Hubner K. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two year follow up: a pilot study. Dig Dis Sci 1985; 30: 642-9.","journal-title":"Dig Dis Sci"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(87)92421-4","article-title":"Ursodexoycholic acid for primary biliary cirrhosis","volume":"ii:","author":"Hofmann, A.F.; Popper, H.","year":"1987","unstructured":"Hofmann AF, Popper H. Ursodexoycholic acid for primary biliary cirrhosis. Lancet 1987; ii: 398-9.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000171240","article-title":"Update on primary biliary cirrhosis","volume":"8","author":"Triger, DR","year":"1990","unstructured":"Triger DR. Update on primary biliary cirrhosis. Dig Dis 1990; 8:61-70.","journal-title":"Dig Dis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-2008-1040505","article-title":"Medical treatment of primary biliary cirrhosis","volume":"9","author":"Kaplan, M.M.","year":"1989","unstructured":"Kaplan MM. Medical treatment of primary biliary cirrhosis. Semin Liver Dis 1989; 9: 138-43.","journal-title":"Semin Liver Dis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1042\/bj2420825","article-title":"Solubilisation of lipids from hamster bile canalicular and contiguous membranes and from human erythrocyte membranes by conjugated bile salts","volume":"242","author":"Graham, J.M.; Northfield, T.C.","year":"1987","unstructured":"Graham JM, Northfield TC. Solubilisation of lipids from hamster bile canalicular and contiguous membranes and from human erythrocyte membranes by conjugated bile salts. BiochemJr 1987; 242: 825-34.","journal-title":"BiochemJr"},{"key":"ref_8","article-title":"Influence of ursodeoxycholic acid on biochemical parameters in cholestatic","volume-title":"liver disease [Abstract]. Gastroenterology 1986; 90: 1725","author":"Fisher, M.M.; Paradine, M.E.","unstructured":"Fisher MM, Paradine ME. Influence of ursodeoxycholic acid on biochemical parameters in cholestatic liver disease [Abstract]. Gastroenterology 1986; 90: 1725."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"ii:","author":"Poupon, R.; Chretien, Y.; Poupon, R.E.","year":"1987","unstructured":"Poupon R, Chretien Y, Poupon RE, et al. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 1987; ii: 834-6.","journal-title":"Lancet"},{"key":"ref_10","first-page":"11","article-title":"Safety of ursodeoxycholic acid in chronic cholestasis","volume":"8","author":"Lotterer, E.; Bauer, F.E.; Bircher, J.","year":"1988","unstructured":"Lotterer E, Bauer FE, Bircher J. Safety of ursodeoxycholic acid in chronic cholestasis [Abstract]. Hepatology 1988; 8: 11 Hayashi H, Higuchi T, Ichimaya H, et at. Ursodeoxycholic acid reduces secondary liver damage in primary biliary cirrhosis and primary sclerosing cholangitis [Abstract]. Hepatology 1988; 8: 1417.","journal-title":"Hepatology; Ursodeoxycholic acid reduces secondary liver damage in primary biliary cirrhosis and primary sclerosing cholangitis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0140-6736(89)92888-2","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis","volume":"i:","author":"Bateson, M.C.; Ross, P.E.; Diffey, B.L.","year":"1989","unstructured":"Bateson MC, Ross PE, Diffey BL. Ursodeoxycholic acid in primary biliary cirrhosis. Lancet 1989; i: 898-9.","journal-title":"Lancet"},{"key":"ref_12","first-page":"15","article-title":"Improvement of biliary enzyme levels and itching as a result of long term administration of ursodeoxycholic acid in primary biliary cirrhosis. AmJr Gastroenterol","volume":"85","author":"Matsuzaki, Y.; Tanaka, N.; Osuga, T.","year":"1990","unstructured":"Matsuzaki Y, Tanaka N, Osuga T, et al. Improvement of biliary enzyme levels and itching as a result of long term administration of ursodeoxycholic acid in primary biliary cirrhosis. AmJr Gastroenterol 1990; 85: 15-23."},{"issue":"49-5","key":"ref_13","first-page":"1","article-title":"Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis","volume":"34","author":"Osuga, T.; Tanaka, N.; Matsuzaki, Y.; Aikawa, T.","year":"1989","unstructured":"Osuga T, Tanaka N, Matsuzaki Y, Aikawa T. Effect of ursodeoxycholic acid in chronic hepatitis and primary biliary cirrhosis. Dig Dis Sci 1989; 34 (suppl): 49-5 1.","journal-title":"Dig Dis Sci"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0016-5085(89)91698-3","article-title":"Ursodeoxycholic acid in primary biliary cirrhosis: results of a double blind controlled trial","volume":"97","author":"Leuschner, U.; Fischer, H.; Kurtz, W.","year":"1989","unstructured":"Leuschner U, Fischer H, Kurtz W, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a double blind controlled trial. Gastroenterology 1989; 97: 1268-74.","journal-title":"Gastroenterology"},{"key":"ref_15","first-page":"580","article-title":"A randomized controlled study of ursodeoxycholic acid in primary biliary cirrhosis","volume":"10","author":"Hadziyannis, S.J.; Hadziyannis, E.S.; Makris, A.","year":"1989","unstructured":"Hadziyannis SJ, Hadziyannis ES, Makris A. A randomized controlled study of ursodeoxycholic acid in primary biliary cirrhosis [Abstract]. Hepatology 1989; 10: 580.","journal-title":"Hepatology"},{"key":"ref_16","first-page":"639","article-title":"Ursodeoxycholic acid for symptomatic primary biliary cirrhosis: a double blind multicenter study","volume":"10","author":"Podda, M.; Battezzati, P.M.; Crosignani, A.","year":"1989","unstructured":"Podda M, Battezzati PM, Crosignani A, et al. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis: a double blind multicenter study [Abstract]. Hepatology 1989; 10: 639.","journal-title":"Hepatology"},{"key":"ref_17","first-page":"617","article-title":"Ursodiol in the treatment of primary biliary cirrhosis","volume":"98","author":"O'Brien, C.B.; Senior, JR, Sternlieb; J.M.","year":"1990","unstructured":"O'Brien CB, Senior JR, Sternlieb JM, et al. Ursodiol in the treatment of primary biliary cirrhosis. Gastroenterology 1990; 98: A617.","journal-title":"Gastroenterology"},{"key":"ref_18","first-page":"237","article-title":"Acide ursodeoxycholique dans la cirrhose bilaire primitive: premiere etude en double aveugle","volume":"16","author":"Roseau, G.","year":"1990","unstructured":"Roseau G. Acide ursodeoxycholique dans la cirrhose bilaire primitive: premiere etude en double aveugle [Abstract]. Presse Med 1990; 16: 237."},{"key":"ref_19","article-title":"A multicenter double blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis in Japan. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 76)","author":"Toda, G.; Oka, H.; Hasumura, Y.","year":"1990","unstructured":"Toda G, Oka H, Hasumura Y, et al. A multicenter double blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis in Japan. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 76). Freiburg, Germany: Falk symposium No 58, 1990."},{"key":"ref_20","first-page":"16","article-title":"UDCA-PBC study group. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis: interim analysis of a double blind multicentre randomised trial","volume":"11","author":"Poupon, R.E.; Eschwege, E.; Poupon, R.","year":"1990","unstructured":"Poupon RE, Eschwege E, Poupon R, UDCA-PBC study group. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis: interim analysis of a double blind multicentre randomised trial. J Hepatol 1990; 11: 16-21.","journal-title":"J Hepatol"},{"key":"ref_21","first-page":"1163","article-title":"Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid","volume":"i:","author":"Vogel, W.; Kathrein, H.; Judmaier, G.; Braunsteiner, H.","year":"1988","unstructured":"Vogel W, Kathrein H, Judmaier G, Braunsteiner H. Deterioration of primary biliary cirrhosis during treatment with ursodeoxycholic acid. Lancet 1988; i: 1163.","journal-title":"Lancet"},{"key":"ref_22","first-page":"647","article-title":"Influence of urosdeoxycholic acid on primary biliary cirrhosis depending on stage","volume-title":"of the disease. Gastroenterology 1989; 96","author":"Raedsch, R.; Stiehl, A.; Theilmann, L.","unstructured":"Raedsch R, Stiehl A, Theilmann L, et al. Influence of urosdeoxycholic acid on primary biliary cirrhosis depending on stage of the disease. Gastroenterology 1989; 96: A647."},{"key":"ref_23","first-page":"640","article-title":"Ursodeoxycholic acid treatment produces marked clinical and biochemical amelioration of primary sclerosing cholangitis","volume":"96","author":"O'Brien, C.B.; Senior, JR, Batta; A.K.","year":"1989","unstructured":"O'Brien CB, Senior JR, Batta AK, et al. Ursodeoxycholic acid treatment produces marked clinical and biochemical amelioration of primary sclerosing cholangitis. Gastroenterology 1989; 96: A640.","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(90)90281-U","article-title":"Ursodeoxycholic acid for primary sclerosing cholangitis","volume":"11","author":"Chazouillieres 0, Poupon R, Capron JP","year":"1990","unstructured":"Chazouillieres 0, Poupon R, Capron JP, et al. Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol 1990; 11: 120-3.","journal-title":"J Hepatol"},{"key":"ref_25","first-page":"602","article-title":"Treatment of primary sclerosing cholangitis with ursodeoxycholic acid: first results of a controlled study","volume":"10","author":"Stiehl, A.; Raedsch, R.; Rudolph, G.; Thielmann, L.","year":"1989","unstructured":"Stiehl A, Raedsch R, Rudolph G, Thielmann L. Treatment of primary sclerosing cholangitis with ursodeoxycholic acid: first results of a controlled study [Abstract]. Hepatology 1989; 10:602.","journal-title":"Hepatology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/gut.31.8.918","article-title":"Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis","volume":"31","author":"Cotting, J.; Mj, Lentze; Reichen, J.","year":"1990","unstructured":"Cotting J, Lentze Mj, Reichen J. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut 1990; 31: 918-21.","journal-title":"Gut"},{"issue":"1990","key":"ref_27","first-page":"67","article-title":"The effect of treatment with ursodeoxycholic acid in cystic fibrosis with hepatopathy: results of a placebo controlled study. In: Meeting Handbook, XIth International Bile Acid Meeting","volume":"58","author":"Bittner, P.; Sailer, T.; Ott, H.","unstructured":"Bittner P, Sailer T, Ott H, et al. The effect of treatment with ursodeoxycholic acid in cystic fibrosis with hepatopathy: results of a placebo controlled study. In: Meeting Handbook, XIth International Bile Acid Meeting [Abstract]. Freiburg, Germany: Falk symposium No 58, 1990: 67."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/bjs.1800730819","article-title":"A randomised clinical trial of ursodeoxycholic acid in odstructive jaundice","volume":"73","author":"Thompson, J.N.; Cohen, J.; Blenkham, J.I.","year":"1986","unstructured":"Thompson JN, Cohen J, Blenkham JI, et al. A randomised clinical trial of ursodeoxycholic acid in odstructive jaundice. BrJ Surg 1986; 73: 634-6.","journal-title":"BrJ Surg"},{"key":"ref_29","first-page":"603","article-title":"Short term effects of ursodeoxycholic acid in chronic cholestatic","volume-title":"disorders of childhood. Gastroenterology 1990","volume":"98","author":"Levy, J.; De Felice, A.; Ramakrishnan, R.","unstructured":"Levy J, De Felice A, Ramakrishnan R, et al. Short term effects of ursodeoxycholic acid in chronic cholestatic disorders of childhood. Gastroenterology 1990; 98: A603."},{"key":"ref_30","article-title":"Treatment with ursodeoxycholic acid renders children with bilary atresia suitable for liver transplantation","author":"Ullrich, D.; Rating, D.; Schroter, W.; Hanefeld, F.; Bircher, J.","year":"1987","unstructured":"Ullrich D, Rating D, Schroter W, Hanefeld F, Bircher J. Treatment with ursodeoxycholic acid renders children with bilary atresia suitable for liver transplantation. Lancet 1987; ii: 1324.","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(88)91313-X","article-title":"Ursodeoxycholic acid in biliary atresia","volume":"i:","author":"Nittono, H.; Tokita, A.; Hayashi, M.","year":"1988","unstructured":"Nittono H, Tokita A, Hayashi M, et al. Ursodeoxycholic acid in biliary atresia. Lancet 1988; i: 528.","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0753-3322(89)90189-3","article-title":"Ursodeoxycholic acid therapy in the treatment of biliary atresia","volume":"43","author":"Nittono, H.; Tokito, A.; Hayashi, M.","year":"1989","unstructured":"Nittono H, Tokito A, Hayashi M, et al. Ursodeoxycholic acid therapy in the treatment of biliary atresia. Biomed Pharnacother 1989; 43: 37-41.","journal-title":"Biomed Pharnacother"},{"issue":"1990","key":"ref_33","first-page":"62","article-title":"Effects of ursodeoxycholic acid in patients with cholestasis of pregnancy. In: Meeting Handbook, XIth International Bile Acid Meeting","volume-title":"Falk symposium No","volume":"58","author":"Reyes, H.; Palma, J.; Ribalta, J.","unstructured":"Reyes H, Palma J, Ribalta J, et al. Effects of ursodeoxycholic acid in patients with cholestasis of pregnancy. In: Meeting Handbook, XIth International Bile Acid Meeting. Freiburg, Germany: Falk symposium No 58, 1990: 62."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.1840100632","article-title":"Treatment of patients with benign recurrent intrahepatic cholestasis","volume":"10","author":"Birchner, J.","year":"1989","unstructured":"Birchner J. Treatment of patients with benign recurrent intrahepatic cholestasis. Hepatology 1989; 10: 1030.","journal-title":"Hepatology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0168-8278(89)90155-4","article-title":"Effect of ursodeoxycholic acid on alanine aminotransferase and --glutamyl transferase serum levels in patients with hyper transaminasemia","volume":"8","author":"Bellentani, S.; Tabarroni, G.; Barchi, T.","year":"1989","unstructured":"Bellentani S, Tabarroni G, Barchi T, et al. Effect of ursodeoxycholic acid on alanine aminotransferase and --glutamyl transferase serum levels in patients with hyper transaminasemia. J Hepatol 1989; 8: 7-12.","journal-title":"J Hepatol"},{"key":"ref_36","article-title":"Treatment of non-A non-B chronic hepatitis with ursodeoxycholic acid: results from a prospective double blind controlled trial. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 72)","author":"Ideo, G.; Bellati, G.; Bottelli, R.; Pedraglio, E.","year":"1990","unstructured":"Ideo G, Bellati G, Bottelli R, Pedraglio E. Treatment of non-A non-B chronic hepatitis with ursodeoxycholic acid: results from a prospective double blind controlled trial. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 72). Freiburg, Germany: Falk symposium No 58, 1990."},{"key":"ref_37","first-page":"691","article-title":"Activation of mast cells by bile acids","volume":"96","author":"Quist, R.; Hofmann, A.F.; Barrett, K.E.","year":"1989","unstructured":"Quist R, Hofmann AF, Barrett KE. Activation of mast cells by bile acids. Gastroenterology 1989; 96: A691.","journal-title":"Gastroenterology"},{"key":"ref_38","first-page":"163","article-title":"Effects of bile salts on membranes","volume-title":"lipid metabolism","author":"Salvioli, G.; Lugli, R.; Pradelli, J.M.","year":"1984","unstructured":"Salvioli G, Lugli R, Pradelli JM. Effects of bile salts on membranes. In: Calandra S, Carulli N, Salvioli G, eds. Liver and lipid metabolism. Amsterdam: Excerpta Medica, 1984: 163-79."},{"key":"ref_39","first-page":"607","article-title":"Tauroursodeoxycholate protects against cholestatic and hepatocytolytic toxicity of more hydrophobic bile salts","volume":"96","author":"Heuman, D.M.; Komito, S.F.; Pandak, W.M.; Hylemon, P.B.; Vlahcevic, Z.R.","year":"1989","unstructured":"Heuman DM, Komito SF, Pandak WM, Hylemon PB, Vlahcevic ZR. Tauroursodeoxycholate protects against cholestatic and hepatocytolytic toxicity of more hydrophobic bile salts. Gastroenterology 1989; 96: A607.","journal-title":"Gastroenterology"},{"key":"ref_40","first-page":"599","article-title":"Ursodeoxycholate reduces toxicity of different bile acids in human primary hepatocyte cultures","volume":"96","author":"Galle, P.R.; Theilmann, L.; Kohl, B.; Raedsch, R.; Stiehl, A.","year":"1989","unstructured":"Galle PR, Theilmann L, Kohl B, Raedsch R, Stiehl A. Ursodeoxycholate reduces toxicity of different bile acids in human primary hepatocyte cultures. Gastroenterology 1989; 96: A599.","journal-title":"Gastroenterology"},{"key":"ref_41","first-page":"1357","article-title":"Hepatic injury induced by bile salts and its prevention by tauroursodeoxycholate: correlation between biochemical and morphological events","volume":"8","author":"Schmucker, D.L.; Kitani, K.; Ohta, M.; Kanai, S.; Sato, Y.","year":"1988","unstructured":"Schmucker DL, Kitani K, Ohta M, Kanai S, Sato Y. Hepatic injury induced by bile salts and its prevention by tauroursodeoxycholate: correlation between biochemical and morphological events [Abstract]. Hepatology 1988; 8: 1357.","journal-title":"Hepatology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0024-3205(82)90264-8","article-title":"Tauroursodeoxycholate prevents taurocholate induced cholestasis","volume":"30","author":"Kitani, K.; Kanai, S.","year":"1982","unstructured":"Kitani K, Kanai S. Tauroursodeoxycholate prevents taurocholate induced cholestasis. Life Sci 1982; 30: 515-23.","journal-title":"Life Sci"},{"key":"ref_43","first-page":"139","article-title":"Interactions between different bile salts in the biliary excretion","volume":"39","author":"Kitani, K.; Kanai, S.","year":"1983","unstructured":"Kitani K, Kanai S. Interactions between different bile salts in the biliary excretion. Res Commun Chem Pathol Pharmacol 1983; 39: 139-52.","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"ref_44","first-page":"407","article-title":"Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat","volume":"248","author":"Kitani, K.; Ohta, M.; Kanai, S.","year":"1985","unstructured":"Kitani K, Ohta M, Kanai S. Tauroursodeoxycholate prevents biliary protein excretion induced by other bile salts in the rat. AmJ Physiol 1985; 248: 407-17.","journal-title":"AmJ Physiol"},{"issue":"1990","key":"ref_45","first-page":"45","article-title":"Tauroursodeoxycholate protects cholesterol rich model membranes against disruption by more hydrophobic bile salts. In: Meeting Handbook, XIth International Bile Acid Meeting","volume-title":"Falk symposium No","volume":"58","author":"Heuman, D.M.; Conroy, R.M.","unstructured":"Heuman DM, Conroy RM. Tauroursodeoxycholate protects cholesterol rich model membranes against disruption by more hydrophobic bile salts. In: Meeting Handbook, XIth International Bile Acid Meeting. Freiburg, Germany: Falk symposium No 58, 1990: 45."},{"key":"ref_46","first-page":"35","article-title":"Influence of ursodeoxycholic acid on bile secretion","volume-title":"Strategies for the treatment of hepatobiliary diseases","author":"Erlinger, S.; Dumont, M.","year":"1990","unstructured":"Erlinger S, Dumont M. Influence of ursodeoxycholic acid on bile secretion. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer Academic, 1990: 35-42."},{"key":"ref_47","article-title":"Changes in bile acid composition induced in patients with primary biliary cirrhosis by ursodeoxycholic acid administration. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 67)","author":"Crosignani, A.; Battezzati, P.M.; Camisasca, M.","year":"1990","unstructured":"Crosignani A, Battezzati PM, Camisasca M, et al. Changes in bile acid composition induced in patients with primary biliary cirrhosis by ursodeoxycholic acid administration. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 67). Freiburg, Germany: Falk symposium No 58, 1990."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/gut.30.8.1110","article-title":"Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis","volume":"30","author":"Chretien, Y.; Poupon, R.; Gherardt, M.F.","year":"1989","unstructured":"Chretien Y, Poupon R, Gherardt MF, et al. Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis. Gut 1989; 30: 1110-5.","journal-title":"Gut"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF01536664","article-title":"Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis","volume":"34","author":"Roda, E.; Mazzella, G.; Bazzoli, F.","year":"1989","unstructured":"Roda E, Mazzella G, Bazzoli F, et al. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis. Dig Dis Sci 1989; 34 (suppl): 52-8.","journal-title":"Dig Dis Sci"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/hep.1840100404","article-title":"Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis","volume":"10","author":"Batta, A.K.; Salen, G.; Arora, R.","year":"1989","unstructured":"Batta AK, Salen G, Arora R, et al. Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. Hepatology 1989; 10: 414-9.","journal-title":"Hepatology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/hep.1840120308","article-title":"Ursodeoxycholic acidinduced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis","volume":"12","author":"Stiehl, A.; Rudolph, G.; Raedsch, R.","year":"1990","unstructured":"Stiehl A, Rudolph G, Raedsch R, et al. Ursodeoxycholic acidinduced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. Hepatology 1990; 12: 492-7.","journal-title":"Hepatology"},{"key":"ref_52","article-title":"Effect of ursodeoxycholic acid on hepatic bile acid handling in primary biliary cirrhosis","author":"Jazrawi, R.P.; de Caestecker, J.S.; Brittain, A.","year":"184.","unstructured":"Jazrawi RP, de Caestecker JS, Brittain A, et al. Effect of ursodeoxycholic acid on hepatic bile acid handling in primary biliary cirrhosis. Gut 1990; 31: Al 184."},{"key":"ref_53","article-title":"Ursodeoxycholic acid in patients with cystic fibrosis and liver disease: a doseresponse study. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 66)","author":"Colombo, C.; Setchell, K.D.R.; Podda, M.","year":"1990","unstructured":"Colombo C, Setchell KDR, Podda M, et al. Ursodeoxycholic acid in patients with cystic fibrosis and liver disease: a doseresponse study. In: Meeting Handbook, XIth International Bile Acid Meeting (Poster Abstract No 66). Freiburg, Germany: Falk symposium No 58, 1990."},{"key":"ref_54","first-page":"69","article-title":"Natural history and pathogenesis of primary biliary cirrhosis","volume-title":"Strategies for the treatment of hepatobiliary diseases","author":"Pape, G.R.; Spengler, U.; Jung, M.C.","year":"1990","unstructured":"Pape GR, Spengler U, Jung MC, et al. Natural history and pathogenesis of primary biliary cirrhosis. In: Paumgartner G, Stiehl A, Barbara L, Roda E, eds. Strategies for the treatment of hepatobiliary diseases. Dordrecht: Kluwer Academic, 1990: 69-77."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.1840110104","article-title":"Hepatic expression of class I and II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"11","author":"Calmus, Y.; Gane, P.; Rouger, P.; Poupon, R.","year":"1990","unstructured":"Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990; 11: 12-5.","journal-title":"Hepatology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF01536665","article-title":"Effect of different doses of ursodeoxycholic acid in chronic liver disease","volume":"34","author":"Podda, M.; Ghezzi, C.; Battezzati, P.M.","year":"1989","unstructured":"Podda M, Ghezzi C, Battezzati PM, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 1989; 34: 59-65S.","journal-title":"Dig Dis Sci"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study","volume":"98","author":"Balasubramanian, K.; Grambsch, P.M.; Wesner, R.H.; Lindor, K.D.; Dickson, E.R.","year":"1990","unstructured":"Balasubramanian K, Grambsch PM, Wesner RH, Lindor KD, Dickson ER. Diminished survival in asymptomatic primary biliary cirrhosis: a prospective study. Gastroenterology 1990; 98: 1567.","journal-title":"Gastroenterology"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.32.9.1061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T19:39:43Z","timestamp":1765654783000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.32.9.1061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,9]]},"references-count":57,"journal-issue":{"issue":"9","published-online":{"date-parts":[[1991,9,1]]},"published-print":{"date-parts":[[1991,9]]}},"alternative-id":["10.1136\/gut.32.9.1061"],"URL":"https:\/\/doi.org\/10.1136\/gut.32.9.1061","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,9]]}}}